+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Global Ophthalmic Drugs Market by Dispense Type (Over the Counter, Prescription), Disease Condition (Allergy, Dry Eye Disorder, Glaucoma), Products, Dosage Form, Distribution - Forecast 2024-2030- Product Image
Global Ophthalmic Drugs Market by Dispense Type (Over the Counter, Prescription), Disease Condition (Allergy, Dry Eye Disorder, Glaucoma), Products, Dosage Form, Distribution - Forecast 2024-2030- Product Image
Sale

Global Ophthalmic Drugs Market by Dispense Type (Over the Counter, Prescription), Disease Condition (Allergy, Dry Eye Disorder, Glaucoma), Products, Dosage Form, Distribution - Forecast 2024-2030

  • PDF Icon

    Report

  • 188 Pages
  • March 2024
  • Region: Global
  • 360iResearch™
  • ID: 4968753
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Ophthalmic Drugs Market size was estimated at USD 28.99 billion in 2023, USD 30.56 billion in 2024, and is expected to grow at a CAGR of 5.86% to reach USD 43.21 billion by 2030.

An ophthalmic drug is a medication used to treat eye diseases, disorders, or injuries. These medications can be administered in various ways including topical application, injection into the eye, and systemic administration. The most common type of ophthalmic drugs are antibiotics, anti-inflammatory agents, and glaucoma medications. There is an increasing demand for treatments that target specific eye conditions or diseases, such as glaucoma and age-related macular degeneration creating requirements for effective ophthalmic drugs. However, the cost and time intensive R&D process and possible side effects of drugs may create obstacles for the market growth. Moreover, the development of gene therapy for treating eye diseases has observed significant growth over the past few years, with a number of promising treatments currently being tested and developed. New advancements in AI-based technology have enabled ophthalmic drug manufacturers to improve accuracy and efficiency when it comes to drug delivery and diagnosis.

Regional Insights

The Americas ophthalmic drugs market has observed significant growth in recent years due to the high prevalence of eye-related diseases, the emergence of innovative products such as biologics and biosimilars, and an increase in elderly population requiring eye treatments. Market trends indicate that spending on ophthalmic drugs is expected to continue to increase over the coming years. Furthermore, a growing number of international OTC brands are entering the market, diversifying product offerings. The ophthalmic drugs market in the Asia-Pacific is highly diverse, with various countries having different levels of healthcare investment, improving healthcare infrastructure, and product availability. The market has experienced strong growth year-over-year due to large-scale population countries and increased need for eye care products in the region. Factors such as rising incomes and improved access to healthcare have made ophthalmic drugs more accessible to consumers in the Asia-Pacific. The growing number of clinical trials in Europe for new drug developments contributes to the market growth in the EMEA region. In addition, factors such as increasing sales of branded medications and a rise in R&D investments in ophthalmic drugs are expected to provide significant opportunities for market players across the EMEA region.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Ophthalmic Drugs Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Ophthalmic Drugs Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Ophthalmic Drugs Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Alcon Vision LLC, Allergan PLC by AbbVie Inc., Apotex Inc., Bausch Health Companies Inc., Bayer AG, Carl Zeiss AG, Coherus Biosciences, Inc., EyePoint Pharmaceuticals, Inc., Eyevensys, Genentech, Inc., Johnson & Johnson Service, Inc., Kodiak Sciences Inc., Lupin Limited, Merck & Co., Nicox SA, Novaliq GmbH, Novartis AG, Ocular Therapeutix, Inc., OCuSOFT Inc., Pfizer Inc., Recipharm AB, Regeneron Pharmaceuticals, Inc., Santen Pharmaceutical Co., Ltd., Senju Pharmaceutical Co., Ltd., Somerset Pharma, LLC., Sun Pharmaceutical Industries, Inc., Takeda Pharmaceutical Company Limited, Teva Pharmaceutical Industries Ltd., and Viatris Inc.

Market Segmentation & Coverage

This research report categorizes the Ophthalmic Drugs Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Dispense Type
    • Over the Counter
    • Prescription
  • Disease Condition
    • Allergy
    • Dry Eye Disorder
    • Glaucoma
    • Retinal Disorder
      • Diabetic Retinopathy
      • Dry Age-related Macular Degeneration
      • Wet Age-related Macular Degeneration
  • Products
    • Capsules & Tablets
    • Drops
    • Gels
    • Ointments
    • Solutions & Suspensions
  • Dosage Form
    • Liquid Ophthalmic Drug Forms
    • Multicompartment Drug Delivery Systems
    • Semisolid Ophthalmic Drug Forms
    • Solid Ophthalmic Drug Forms
  • Distribution
    • Drug Stores
    • Hospital Pharmacies
    • Online Pharmacies
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

  1. Market Penetration: It presents comprehensive information on the market provided by key players.
  2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
  3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
  4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
  5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

  1. What is the market size and forecast of the Ophthalmic Drugs Market?
  2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Ophthalmic Drugs Market?
  3. What are the technology trends and regulatory frameworks in the Ophthalmic Drugs Market?
  4. What is the market share of the leading vendors in the Ophthalmic Drugs Market?
  5. Which modes and strategic moves are suitable for entering the Ophthalmic Drugs Market?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.

This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Ophthalmic Drugs Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rise in the prevalence of ophthalmic disorders and indications globally
5.1.1.2. Growing development combination therapies for the treatment of ophthalmic
disorders
5.1.1.3. Increased awareness, treatment accessibility and drug availability
5.1.2. Restraints
5.1.2.1. High development costs and time taking research and development of ophthalmic drugs
5.1.3. Opportunities
5.1.3.1. Increasing investment and R&D activities by vendors to develop novel ophthalmic drugs
5.1.3.2. Significant potential in ophthalmic biologics
5.1.4. Challenges
5.1.4.1. Unmonitored side effects of ophthalmic drugs
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
6. Ophthalmic Drugs Market, by Dispense Type
6.1. Introduction
6.2. Over the Counter
6.3. Prescription
7. Ophthalmic Drugs Market, by Disease Condition
7.1. Introduction
7.2. Allergy
7.3. Dry Eye Disorder
7.4. Glaucoma
7.5. Retinal Disorder
7.6.1. Diabetic Retinopathy
7.6.2. Dry Age-related Macular Degeneration
7.6.3. Wet Age-related Macular Degeneration
8. Ophthalmic Drugs Market, by Products
8.1. Introduction
8.2. Capsules & Tablets
8.3. Drops
8.4. Gels
8.5. Ointments
8.6. Solutions & Suspensions
9. Ophthalmic Drugs Market, by Dosage Form
9.1. Introduction
9.2. Liquid Ophthalmic Drug Forms
9.3. Multicompartment Drug Delivery Systems
9.4. Semisolid Ophthalmic Drug Forms
9.5. Solid Ophthalmic Drug Forms
10. Ophthalmic Drugs Market, by Distribution
10.1. Introduction
10.2. Drug Stores
10.3. Hospital Pharmacies
10.4. Online Pharmacies
11. Americas Ophthalmic Drugs Market
11.1. Introduction
11.2. Argentina
11.3. Brazil
11.4. Canada
11.5. Mexico
11.6. United States
12. Asia-Pacific Ophthalmic Drugs Market
12.1. Introduction
12.2. Australia
12.3. China
12.4. India
12.5. Indonesia
12.6. Japan
12.7. Malaysia
12.8. Philippines
12.9. Singapore
12.10. South Korea
12.11. Taiwan
12.12. Thailand
12.13. Vietnam
13. Europe, Middle East & Africa Ophthalmic Drugs Market
13.1. Introduction
13.2. Denmark
13.3. Egypt
13.4. Finland
13.5. France
13.6. Germany
13.7. Israel
13.8. Italy
13.9. Netherlands
13.10. Nigeria
13.11. Norway
13.12. Poland
13.13. Qatar
13.14. Russia
13.15. Saudi Arabia
13.16. South Africa
13.17. Spain
13.18. Sweden
13.19. Switzerland
13.20. Turkey
13.21. United Arab Emirates
13.22. United Kingdom
14. Competitive Landscape
14.1. FPNV Positioning Matrix
14.2. Market Share Analysis, By Key Player
14.3. Competitive Scenario Analysis, By Key Player
14.3.1. Merger & Acquisition
14.3.1.1. Bausch + Lomb Plans to Acquire XIIDRA
14.3.2. Agreement, Collaboration, & Partnership
14.3.2.1. Eyenovia and Formosa Partner For New Ophthalmic Therapeutics
14.3.3. Investment & Funding
14.3.3.1. Re-Vana Reels in USD 12M To Develop Sustained-Release Eye Implants
14.3.4. Award, Recognition, & Expansion
14.3.4.1. FDA Approves Novaliq’s Cyclosporine Ophthalmic Solution For Treatment Of Dry Eye Disease
15. Competitive Portfolio
15.1. Key Company Profiles
15.1.1. Abbott Laboratories
15.1.2. Alcon Vision LLC
15.1.3. Allergan PLC by AbbVie Inc.
15.1.4. Apotex Inc.
15.1.5. Bausch Health Companies Inc.
15.1.6. Bayer AG
15.1.7. Carl Zeiss AG
15.1.8. Coherus Biosciences, Inc.
15.1.9. EyePoint Pharmaceuticals, Inc.
15.1.10. Eyevensys
15.1.11. Genentech, Inc.
15.1.12. Johnson & Johnson Service, Inc.
15.1.13. Kodiak Sciences Inc.
15.1.14. Lupin Limited
15.1.15. Merck & Co.
15.1.16. Nicox SA
15.1.17. Novaliq GmbH
15.1.18. Novartis AG
15.1.19. Ocular Therapeutix, Inc.
15.1.20. OCuSOFT Inc.
15.1.21. Pfizer Inc.
15.1.22. Recipharm AB
15.1.23. Regeneron Pharmaceuticals, Inc.
15.1.24. Santen Pharmaceutical Co., Ltd.
15.1.25. Senju Pharmaceutical Co., Ltd.
15.1.26. Somerset Pharma, LLC.
15.1.27. Sun Pharmaceutical Industries, Inc.
15.1.28. Takeda Pharmaceutical Company Limited
15.1.29. Teva Pharmaceutical Industries Ltd.
15.1.30. Viatris Inc.
15.2. Key Product Portfolio
16. Appendix
16.1. Discussion Guide
16.2. License & Pricing
List of Figures
FIGURE 1. OPHTHALMIC DRUGS MARKET RESEARCH PROCESS
FIGURE 2. OPHTHALMIC DRUGS MARKET SIZE, 2023 VS 2030
FIGURE 3. OPHTHALMIC DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. OPHTHALMIC DRUGS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. OPHTHALMIC DRUGS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. OPHTHALMIC DRUGS MARKET DYNAMICS
FIGURE 7. OPHTHALMIC DRUGS MARKET SIZE, BY DISPENSE TYPE, 2023 VS 2030 (%)
FIGURE 8. OPHTHALMIC DRUGS MARKET SIZE, BY DISPENSE TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. OPHTHALMIC DRUGS MARKET SIZE, BY DISEASE CONDITION, 2023 VS 2030 (%)
FIGURE 10. OPHTHALMIC DRUGS MARKET SIZE, BY DISEASE CONDITION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. OPHTHALMIC DRUGS MARKET SIZE, BY PRODUCTS, 2023 VS 2030 (%)
FIGURE 12. OPHTHALMIC DRUGS MARKET SIZE, BY PRODUCTS, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. OPHTHALMIC DRUGS MARKET SIZE, BY DOSAGE FORM, 2023 VS 2030 (%)
FIGURE 14. OPHTHALMIC DRUGS MARKET SIZE, BY DOSAGE FORM, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. OPHTHALMIC DRUGS MARKET SIZE, BY DISTRIBUTION, 2023 VS 2030 (%)
FIGURE 16. OPHTHALMIC DRUGS MARKET SIZE, BY DISTRIBUTION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS OPHTHALMIC DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. AMERICAS OPHTHALMIC DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES OPHTHALMIC DRUGS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 20. UNITED STATES OPHTHALMIC DRUGS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC OPHTHALMIC DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC OPHTHALMIC DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 23. EUROPE, MIDDLE EAST & AFRICA OPHTHALMIC DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 24. EUROPE, MIDDLE EAST & AFRICA OPHTHALMIC DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 25. OPHTHALMIC DRUGS MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 26. OPHTHALMIC DRUGS MARKET SHARE, BY KEY PLAYER, 2023
List of Tables
TABLE 1. OPHTHALMIC DRUGS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. OPHTHALMIC DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL OPHTHALMIC DRUGS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. OPHTHALMIC DRUGS MARKET SIZE, BY DISPENSE TYPE, 2018-2030 (USD MILLION)
TABLE 6. OPHTHALMIC DRUGS MARKET SIZE, BY OVER THE COUNTER, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. OPHTHALMIC DRUGS MARKET SIZE, BY PRESCRIPTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. OPHTHALMIC DRUGS MARKET SIZE, BY DISEASE CONDITION, 2018-2030 (USD MILLION)
TABLE 9. OPHTHALMIC DRUGS MARKET SIZE, BY ALLERGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. OPHTHALMIC DRUGS MARKET SIZE, BY DRY EYE DISORDER, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. OPHTHALMIC DRUGS MARKET SIZE, BY GLAUCOMA, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. OPHTHALMIC DRUGS MARKET SIZE, BY RETINAL DISORDER, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. OPHTHALMIC DRUGS MARKET SIZE, BY RETINAL DISORDER, 2018-2030 (USD MILLION)
TABLE 14. OPHTHALMIC DRUGS MARKET SIZE, BY DIABETIC RETINOPATHY, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. OPHTHALMIC DRUGS MARKET SIZE, BY DRY AGE-RELATED MACULAR DEGENERATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. OPHTHALMIC DRUGS MARKET SIZE, BY WET AGE-RELATED MACULAR DEGENERATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. OPHTHALMIC DRUGS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 18. OPHTHALMIC DRUGS MARKET SIZE, BY CAPSULES & TABLETS, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. OPHTHALMIC DRUGS MARKET SIZE, BY DROPS, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. OPHTHALMIC DRUGS MARKET SIZE, BY GELS, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. OPHTHALMIC DRUGS MARKET SIZE, BY OINTMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. OPHTHALMIC DRUGS MARKET SIZE, BY SOLUTIONS & SUSPENSIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. OPHTHALMIC DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 24. OPHTHALMIC DRUGS MARKET SIZE, BY LIQUID OPHTHALMIC DRUG FORMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. OPHTHALMIC DRUGS MARKET SIZE, BY MULTICOMPARTMENT DRUG DELIVERY SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. OPHTHALMIC DRUGS MARKET SIZE, BY SEMISOLID OPHTHALMIC DRUG FORMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. OPHTHALMIC DRUGS MARKET SIZE, BY SOLID OPHTHALMIC DRUG FORMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. OPHTHALMIC DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 29. OPHTHALMIC DRUGS MARKET SIZE, BY DRUG STORES, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. OPHTHALMIC DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. OPHTHALMIC DRUGS MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. AMERICAS OPHTHALMIC DRUGS MARKET SIZE, BY DISPENSE TYPE, 2018-2030 (USD MILLION)
TABLE 33. AMERICAS OPHTHALMIC DRUGS MARKET SIZE, BY DISEASE CONDITION, 2018-2030 (USD MILLION)
TABLE 34. AMERICAS OPHTHALMIC DRUGS MARKET SIZE, BY RETINAL DISORDER, 2018-2030 (USD MILLION)
TABLE 35. AMERICAS OPHTHALMIC DRUGS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 36. AMERICAS OPHTHALMIC DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 37. AMERICAS OPHTHALMIC DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 38. AMERICAS OPHTHALMIC DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 39. ARGENTINA OPHTHALMIC DRUGS MARKET SIZE, BY DISPENSE TYPE, 2018-2030 (USD MILLION)
TABLE 40. ARGENTINA OPHTHALMIC DRUGS MARKET SIZE, BY DISEASE CONDITION, 2018-2030 (USD MILLION)
TABLE 41. ARGENTINA OPHTHALMIC DRUGS MARKET SIZE, BY RETINAL DISORDER, 2018-2030 (USD MILLION)
TABLE 42. ARGENTINA OPHTHALMIC DRUGS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 43. ARGENTINA OPHTHALMIC DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 44. ARGENTINA OPHTHALMIC DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 45. BRAZIL OPHTHALMIC DRUGS MARKET SIZE, BY DISPENSE TYPE, 2018-2030 (USD MILLION)
TABLE 46. BRAZIL OPHTHALMIC DRUGS MARKET SIZE, BY DISEASE CONDITION, 2018-2030 (USD MILLION)
TABLE 47. BRAZIL OPHTHALMIC DRUGS MARKET SIZE, BY RETINAL DISORDER, 2018-2030 (USD MILLION)
TABLE 48. BRAZIL OPHTHALMIC DRUGS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 49. BRAZIL OPHTHALMIC DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 50. BRAZIL OPHTHALMIC DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 51. CANADA OPHTHALMIC DRUGS MARKET SIZE, BY DISPENSE TYPE, 2018-2030 (USD MILLION)
TABLE 52. CANADA OPHTHALMIC DRUGS MARKET SIZE, BY DISEASE CONDITION, 2018-2030 (USD MILLION)
TABLE 53. CANADA OPHTHALMIC DRUGS MARKET SIZE, BY RETINAL DISORDER, 2018-2030 (USD MILLION)
TABLE 54. CANADA OPHTHALMIC DRUGS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 55. CANADA OPHTHALMIC DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 56. CANADA OPHTHALMIC DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 57. MEXICO OPHTHALMIC DRUGS MARKET SIZE, BY DISPENSE TYPE, 2018-2030 (USD MILLION)
TABLE 58. MEXICO OPHTHALMIC DRUGS MARKET SIZE, BY DISEASE CONDITION, 2018-2030 (USD MILLION)
TABLE 59. MEXICO OPHTHALMIC DRUGS MARKET SIZE, BY RETINAL DISORDER, 2018-2030 (USD MILLION)
TABLE 60. MEXICO OPHTHALMIC DRUGS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 61. MEXICO OPHTHALMIC DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 62. MEXICO OPHTHALMIC DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 63. UNITED STATES OPHTHALMIC DRUGS MARKET SIZE, BY DISPENSE TYPE, 2018-2030 (USD MILLION)
TABLE 64. UNITED STATES OPHTHALMIC DRUGS MARKET SIZE, BY DISEASE CONDITION, 2018-2030 (USD MILLION)
TABLE 65. UNITED STATES OPHTHALMIC DRUGS MARKET SIZE, BY RETINAL DISORDER, 2018-2030 (USD MILLION)
TABLE 66. UNITED STATES OPHTHALMIC DRUGS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 67. UNITED STATES OPHTHALMIC DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 68. UNITED STATES OPHTHALMIC DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 69. UNITED STATES OPHTHALMIC DRUGS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 70. ASIA-PACIFIC OPHTHALMIC DRUGS MARKET SIZE, BY DISPENSE TYPE, 2018-2030 (USD MILLION)
TABLE 71. ASIA-PACIFIC OPHTHALMIC DRUGS MARKET SIZE, BY DISEASE CONDITION, 2018-2030 (USD MILLION)
TABLE 72. ASIA-PACIFIC OPHTHALMIC DRUGS MARKET SIZE, BY RETINAL DISORDER, 2018-2030 (USD MILLION)
TABLE 73. ASIA-PACIFIC OPHTHALMIC DRUGS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 74. ASIA-PACIFIC OPHTHALMIC DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 75. ASIA-PACIFIC OPHTHALMIC DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 76. ASIA-PACIFIC OPHTHALMIC DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 77. AUSTRALIA OPHTHALMIC DRUGS MARKET SIZE, BY DISPENSE TYPE, 2018-2030 (USD MILLION)
TABLE 78. AUSTRALIA OPHTHALMIC DRUGS MARKET SIZE, BY DISEASE CONDITION, 2018-2030 (USD MILLION)
TABLE 79. AUSTRALIA OPHTHALMIC DRUGS MARKET SIZE, BY RETINAL DISORDER, 2018-2030 (USD MILLION)
TABLE 80. AUSTRALIA OPHTHALMIC DRUGS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 81. AUSTRALIA OPHTHALMIC DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 82. AUSTRALIA OPHTHALMIC DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 83. CHINA OPHTHALMIC DRUGS MARKET SIZE, BY DISPENSE TYPE, 2018-2030 (USD MILLION)
TABLE 84. CHINA OPHTHALMIC DRUGS MARKET SIZE, BY DISEASE CONDITION, 2018-2030 (USD MILLION)
TABLE 85. CHINA OPHTHALMIC DRUGS MARKET SIZE, BY RETINAL DISORDER, 2018-2030 (USD MILLION)
TABLE 86. CHINA OPHTHALMIC DRUGS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 87. CHINA OPHTHALMIC DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 88. CHINA OPHTHALMIC DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 89. INDIA OPHTHALMIC DRUGS MARKET SIZE, BY DISPENSE TYPE, 2018-2030 (USD MILLION)
TABLE 90. INDIA OPHTHALMIC DRUGS MARKET SIZE, BY DISEASE CONDITION, 2018-2030 (USD MILLION)
TABLE 91. INDIA OPHTHALMIC DRUGS MARKET SIZE, BY RETINAL DISORDER, 2018-2030 (USD MILLION)
TABLE 92. INDIA OPHTHALMIC DRUGS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 93. INDIA OPHTHALMIC DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 94. INDIA OPHTHALMIC DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 95. INDONESIA OPHTHALMIC DRUGS MARKET SIZE, BY DISPENSE TYPE, 2018-2030 (USD MILLION)
TABLE 96. INDONESIA OPHTHALMIC DRUGS MARKET SIZE, BY DISEASE CONDITION, 2018-2030 (USD MILLION)
TABLE 97. INDONESIA OPHTHALMIC DRUGS MARKET SIZE, BY RETINAL DISORDER, 2018-2030 (USD MILLION)
TABLE 98. INDONESIA OPHTHALMIC DRUGS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 99. INDONESIA OPHTHALMIC DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 100. INDONESIA OPHTHALMIC DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 101. JAPAN OPHTHALMIC DRUGS MARKET SIZE, BY DISPENSE TYPE, 2018-2030 (USD MILLION)
TABLE 102. JAPAN OPHTHALMIC DRUGS MARKET SIZE, BY DISEASE CONDITION, 2018-2030 (USD MILLION)
TABLE 103. JAPAN OPHTHALMIC DRUGS MARKET SIZE, BY RETINAL DISORDER, 2018-2030 (USD MILLION)
TABLE 104. JAPAN OPHTHALMIC DRUGS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 105. JAPAN OPHTHALMIC DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 106. JAPAN OPHTHALMIC DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 107. MALAYSIA OPHTHALMIC DRUGS MARKET SIZE, BY DISPENSE TYPE, 2018-2030 (USD MILLION)
TABLE 108. MALAYSIA OPHTHALMIC DRUGS MARKET SIZE, BY DISEASE CONDITION, 2018-2030 (USD MILLION)
TABLE 109. MALAYSIA OPHTHALMIC DRUGS MARKET SIZE, BY RETINAL DISORDER, 2018-2030 (USD MILLION)
TABLE 110. MALAYSIA OPHTHALMIC DRUGS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 111. MALAYSIA OPHTHALMIC DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 112. MALAYSIA OPHTHALMIC DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 113. PHILIPPINES OPHTHALMIC DRUGS MARKET SIZE, BY DISPENSE TYPE, 2018-2030 (USD MILLION)
TABLE 114. PHILIPPINES OPHTHALMIC DRUGS MARKET SIZE, BY DISEASE CONDITION, 2018-2030 (USD MILLION)
TABLE 115. PHILIPPINES OPHTHALMIC DRUGS MARKET SIZE, BY RETINAL DISORDER, 2018-2030 (USD MILLION)
TABLE 116. PHILIPPINES OPHTHALMIC DRUGS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 117. PHILIPPINES OPHTHALMIC DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 118. PHILIPPINES OPHTHALMIC DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 119. SINGAPORE OPHTHALMIC DRUGS MARKET SIZE, BY DISPENSE TYPE, 2018-2030 (USD MILLION)
TABLE 120. SINGAPORE OPHTHALMIC DRUGS MARKET SIZE, BY DISEASE CONDITION, 2018-2030 (USD MILLION)
TABLE 121. SINGAPORE OPHTHALMIC DRUGS MARKET SIZE, BY RETINAL DISORDER, 2018-2030 (USD MILLION)
TABLE 122. SINGAPORE OPHTHALMIC DRUGS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 123. SINGAPORE OPHTHALMIC DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 124. SINGAPORE OPHTHALMIC DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 125. SOUTH KOREA OPHTHALMIC DRUGS MARKET SIZE, BY DISPENSE TYPE, 2018-2030 (USD MILLION)
TABLE 126. SOUTH KOREA OPHTHALMIC DRUGS MARKET SIZE, BY DISEASE CONDITION, 2018-2030 (USD MILLION)
TABLE 127. SOUTH KOREA OPHTHALMIC DRUGS MARKET SIZE, BY RETINAL DISORDER, 2018-2030 (USD MILLION)
TABLE 128. SOUTH KOREA OPHTHALMIC DRUGS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 129. SOUTH KOREA OPHTHALMIC DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 130. SOUTH KOREA OPHTHALMIC DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 131. TAIWAN OPHTHALMIC DRUGS MARKET SIZE, BY DISPENSE TYPE, 2018-2030 (USD MILLION)
TABLE 132. TAIWAN OPHTHALMIC DRUGS MARKET SIZE, BY DISEASE CONDITION, 2018-2030 (USD MILLION)
TABLE 133. TAIWAN OPHTHALMIC DRUGS MARKET SIZE, BY RETINAL DISORDER, 2018-2030 (USD MILLION)
TABLE 134. TAIWAN OPHTHALMIC DRUGS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 135. TAIWAN OPHTHALMIC DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 136. TAIWAN OPHTHALMIC DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 137. THAILAND OPHTHALMIC DRUGS MARKET SIZE, BY DISPENSE TYPE, 2018-2030 (USD MILLION)
TABLE 138. THAILAND OPHTHALMIC DRUGS MARKET SIZE, BY DISEASE CONDITION, 2018-2030 (USD MILLION)
TABLE 139. THAILAND OPHTHALMIC DRUGS MARKET SIZE, BY RETINAL DISORDER, 2018-2030 (USD MILLION)
TABLE 140. THAILAND OPHTHALMIC DRUGS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 141. THAILAND OPHTHALMIC DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 142. THAILAND OPHTHALMIC DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 143. VIETNAM OPHTHALMIC DRUGS MARKET SIZE, BY DISPENSE TYPE, 2018-2030 (USD MILLION)
TABLE 144. VIETNAM OPHTHALMIC DRUGS MARKET SIZE, BY DISEASE CONDITION, 2018-2030 (USD MILLION)
TABLE 145. VIETNAM OPHTHALMIC DRUGS MARKET SIZE, BY RETINAL DISORDER, 2018-2030 (USD MILLION)
TABLE 146. VIETNAM OPHTHALMIC DRUGS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 147. VIETNAM OPHTHALMIC DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 148. VIETNAM OPHTHALMIC DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 149. EUROPE, MIDDLE EAST & AFRICA OPHTHALMIC DRUGS MARKET SIZE, BY DISPENSE TYPE, 2018-2030 (USD MILLION)
TABLE 150. EUROPE, MIDDLE EAST & AFRICA OPHTHALMIC DRUGS MARKET SIZE, BY DISEASE CONDITION, 2018-2030 (USD MILLION)
TABLE 151. EUROPE, MIDDLE EAST & AFRICA OPHTHALMIC DRUGS MARKET SIZE, BY RETINAL DISORDER, 2018-2030 (USD MILLION)
TABLE 152. EUROPE, MIDDLE EAST & AFRICA OPHTHALMIC DRUGS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 153. EUROPE, MIDDLE EAST & AFRICA OPHTHALMIC DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 154. EUROPE, MIDDLE EAST & AFRICA OPHTHALMIC DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 155. EUROPE, MIDDLE EAST & AFRICA OPHTHALMIC DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 156. DENMARK OPHTHALMIC DRUGS MARKET SIZE, BY DISPENSE TYPE, 2018-2030 (USD MILLION)
TABLE 157. DENMARK OPHTHALMIC DRUGS MARKET SIZE, BY DISEASE CONDITION, 2018-2030 (USD MILLION)
TABLE 158. DENMARK OPHTHALMIC DRUGS MARKET SIZE, BY RETINAL DISORDER, 2018-2030 (USD MILLION)
TABLE 159. DENMARK OPHTHALMIC DRUGS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 160. DENMARK OPHTHALMIC DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 161. DENMARK OPHTHALMIC DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 162. EGYPT OPHTHALMIC DRUGS MARKET SIZE, BY DISPENSE TYPE, 2018-2030 (USD MILLION)
TABLE 163. EGYPT OPHTHALMIC DRUGS MARKET SIZE, BY DISEASE CONDITION, 2018-2030 (USD MILLION)
TABLE 164. EGYPT OPHTHALMIC DRUGS MARKET SIZE, BY RETINAL DISORDER, 2018-2030 (USD MILLION)
TABLE 165. EGYPT OPHTHALMIC DRUGS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 166. EGYPT OPHTHALMIC DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 167. EGYPT OPHTHALMIC DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 168. FINLAND OPHTHALMIC DRUGS MARKET SIZE, BY DISPENSE TYPE, 2018-2030 (USD MILLION)
TABLE 169. FINLAND OPHTHALMIC DRUGS MARKET SIZE, BY DISEASE CONDITION, 2018-2030 (USD MILLION)
TABLE 170. FINLAND OPHTHALMIC DRUGS MARKET SIZE, BY RETINAL DISORDER, 2018-2030 (USD MILLION)
TABLE 171. FINLAND OPHTHALMIC DRUGS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 172. FINLAND OPHTHALMIC DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 173. FINLAND OPHTHALMIC DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 174. FRANCE OPHTHALMIC DRUGS MARKET SIZE, BY DISPENSE TYPE, 2018-2030 (USD MILLION)
TABLE 175. FRANCE OPHTHALMIC DRUGS MARKET SIZE, BY DISEASE CONDITION, 2018-2030 (USD MILLION)
TABLE 176. FRANCE OPHTHALMIC DRUGS MARKET SIZE, BY RETINAL DISORDER, 2018-2030 (USD MILLION)
TABLE 177. FRANCE OPHTHALMIC DRUGS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 178. FRANCE OPHTHALMIC DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 179. FRANCE OPHTHALMIC DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 180. GERMANY OPHTHALMIC DRUGS MARKET SIZE, BY DISPENSE TYPE, 2018-2030 (USD MILLION)
TABLE 181. GERMANY OPHTHALMIC DRUGS MARKET SIZE, BY DISEASE CONDITION, 2018-2030 (USD MILLION)
TABLE 182. GERMANY OPHTHALMIC DRUGS MARKET SIZE, BY RETINAL DISORDER, 2018-2030 (USD MILLION)
TABLE 183. GERMANY OPHTHALMIC DRUGS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 184. GERMANY OPHTHALMIC DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 185. GERMANY OPHTHALMIC DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 186. ISRAEL OPHTHALMIC DRUGS MARKET SIZE, BY DISPENSE TYPE, 2018-2030 (USD MILLION)
TABLE 187. ISRAEL OPHTHALMIC DRUGS MARKET SIZE, BY DISEASE CONDITION, 2018-2030 (USD MILLION)
TABLE 188. ISRAEL OPHTHALMIC DRUGS MARKET SIZE, BY RETINAL DISORDER, 2018-2030 (USD MILLION)
TABLE 189. ISRAEL OPHTHALMIC DRUGS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 190. ISRAEL OPHTHALMIC DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 191. ISRAEL OPHTHALMIC DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 192. ITALY OPHTHALMIC DRUGS MARKET SIZE, BY DISPENSE TYPE, 2018-2030 (USD MILLION)
TABLE 193. ITALY OPHTHALMIC DRUGS MARKET SIZE, BY DISEASE CONDITION, 2018-2030 (USD MILLION)
TABLE 194. ITALY OPHTHALMIC DRUGS MARKET SIZE, BY RETINAL DISORDER, 2018-2030 (USD MILLION)
TABLE 195. ITALY OPHTHALMIC DRUGS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 196. ITALY OPHTHALMIC DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 197. ITALY OPHTHALMIC DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 198. NETHERLANDS OPHTHALMIC DRUGS MARKET SIZE, BY DISPENSE TYPE, 2018-2030 (USD MILLION)
TABLE 199. NETHERLANDS OPHTHALMIC DRUGS MARKET SIZE, BY DISEASE CONDITION, 2018-2030 (USD MILLION)
TABLE 200. NETHERLANDS OPHTHALMIC DRUGS MARKET SIZE, BY RETINAL DISORDER, 2018-2030 (USD MILLION)
TABLE 201. NETHERLANDS OPHTHALMIC DRUGS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 202. NETHERLANDS OPHTHALMIC DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 203. NETHERLANDS OPHTHALMIC DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 204. NIGERIA OPHTHALMIC DRUGS MARKET SIZE, BY DISPENSE TYPE, 2018-2030 (USD MILLION)
TABLE 205. NIGERIA OPHTHALMIC DRUGS MARKET SIZE, BY DISEASE CONDITION, 2018-2030 (USD MILLION)
TABLE 206. NIGERIA OPHTHALMIC DRUGS MARKET SIZE, BY RETINAL DISORDER, 2018-2030 (USD MILLION)
TABLE 207. NIGERIA OPHTHALMIC DRUGS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 208. NIGERIA OPHTHALMIC DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 209. NIGERIA OPHTHALMIC DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 210. NORWAY OPHTHALMIC DRUGS MARKET SIZE, BY DISPENSE TYPE, 2018-2030 (USD MILLION)
TABLE 211. NORWAY OPHTHALMIC DRUGS MARKET SIZE, BY DISEASE CONDITION, 2018-2030 (USD MILLION)
TABLE 212. NORWAY OPHTHALMIC DRUGS MARKET SIZE, BY RETINAL DISORDER, 2018-2030 (USD MILLION)
TABLE 213. NORWAY OPHTHALMIC DRUGS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 214. NORWAY OPHTHALMIC DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 215. NORWAY OPHTHALMIC DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 216. POLAND OPHTHALMIC DRUGS MARKET SIZE, BY DISPENSE TYPE, 2018-2030 (USD MILLION)
TABLE 217. POLAND OPHTHALMIC DRUGS MARKET SIZE, BY DISEASE CONDITION, 2018-2030 (USD MILLION)
TABLE 218. POLAND OPHTHALMIC DRUGS MARKET SIZE, BY RETINAL DISORDER, 2018-2030 (USD MILLION)
TABLE 219. POLAND OPHTHALMIC DRUGS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 220. POLAND OPHTHALMIC DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 221. POLAND OPHTHALMIC DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 222. QATAR OPHTHALMIC DRUGS MARKET SIZE, BY DISPENSE TYPE, 2018-2030 (USD MILLION)
TABLE 223. QATAR OPHTHALMIC DRUGS MARKET SIZE, BY DISEASE CONDITION, 2018-2030 (USD MILLION)
TABLE 224. QATAR OPHTHALMIC DRUGS MARKET SIZE, BY RETINAL DISORDER, 2018-2030 (USD MILLION)
TABLE 225. QATAR OPHTHALMIC DRUGS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 226. QATAR OPHTHALMIC DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 227. QATAR OPHTHALMIC DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 228. RUSSIA OPHTHALMIC DRUGS MARKET SIZE, BY DISPENSE TYPE, 2018-2030 (USD MILLION)
TABLE 229. RUSSIA OPHTHALMIC DRUGS MARKET SIZE, BY DISEASE CONDITION, 2018-2030 (USD MILLION)
TABLE 230. RUSSIA OPHTHALMIC DRUGS MARKET SIZE, BY RETINAL DISORDER, 2018-2030 (USD MILLION)
TABLE 231. RUSSIA OPHTHALMIC DRUGS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 232. RUSSIA OPHTHALMIC DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 233. RUSSIA OPHTHALMIC DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 234. SAUDI ARABIA OPHTHALMIC DRUGS MARKET SIZE, BY DISPENSE TYPE, 2018-2030 (USD MILLION)
TABLE 235. SAUDI ARABIA OPHTHALMIC DRUGS MARKET SIZE, BY DISEASE CONDITION, 2018-2030 (USD MILLION)
TABLE 236. SAUDI ARABIA OPHTHALMIC DRUGS MARKET SIZE, BY RETINAL DISORDER, 2018-2030 (USD MILLION)
TABLE 237. SAUDI ARABIA OPHTHALMIC DRUGS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 238. SAUDI ARABIA OPHTHALMIC DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 239. SAUDI ARABIA OPHTHALMIC DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 240. SOUTH AFRICA OPHTHALMIC DRUGS MARKET SIZE, BY DISPENSE TYPE, 2018-2030 (USD MILLION)
TABLE 241. SOUTH AFRICA OPHTHALMIC DRUGS MARKET SIZE, BY DISEASE CONDITION, 2018-2030 (USD MILLION)
TABLE 242. SOUTH AFRICA OPHTHALMIC DRUGS MARKET SIZE, BY RETINAL DISORDER, 2018-2030 (USD MILLION)
TABLE 243. SOUTH AFRICA OPHTHALMIC DRUGS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 244. SOUTH AFRICA OPHTHALMIC DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 245. SOUTH AFRICA OPHTHALMIC DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 246. SPAIN OPHTHALMIC DRUGS MARKET SIZE, BY DISPENSE TYPE, 2018-2030 (USD MILLION)
TABLE 247. SPAIN OPHTHALMIC DRUGS MARKET SIZE, BY DISEASE CONDITION, 2018-2030 (USD MILLION)
TABLE 248. SPAIN OPHTHALMIC DRUGS MARKET SIZE, BY RETINAL DISORDER, 2018-2030 (USD MILLION)
TABLE 249. SPAIN OPHTHALMIC DRUGS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 250. SPAIN OPHTHALMIC DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 251. SPAIN OPHTHALMIC DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 252. SWEDEN OPHTHALMIC DRUGS MARKET SIZE, BY DISPENSE TYPE, 2018-2030 (USD MILLION)
TABLE 253. SWEDEN OPHTHALMIC DRUGS MARKET SIZE, BY DISEASE CONDITION, 2018-2030 (USD MILLION)
TABLE 254. SWEDEN OPHTHALMIC DRUGS MARKET SIZE, BY RETINAL DISORDER, 2018-2030 (USD MILLION)
TABLE 255. SWEDEN OPHTHALMIC DRUGS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 256. SWEDEN OPHTHALMIC DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 257. SWEDEN OPHTHALMIC DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 258. SWITZERLAND OPHTHALMIC DRUGS MARKET SIZE, BY DISPENSE TYPE, 2018-2030 (USD MILLION)
TABLE 259. SWITZERLAND OPHTHALMIC DRUGS MARKET SIZE, BY DISEASE CONDITION, 2018-2030 (USD MILLION)
TABLE 260. SWITZERLAND OPHTHALMIC DRUGS MARKET SIZE, BY RETINAL DISORDER, 2018-2030 (USD MILLION)
TABLE 261. SWITZERLAND OPHTHALMIC DRUGS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 262. SWITZERLAND OPHTHALMIC DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 263. SWITZERLAND OPHTHALMIC DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 264. TURKEY OPHTHALMIC DRUGS MARKET SIZE, BY DISPENSE TYPE, 2018-2030 (USD MILLION)
TABLE 265. TURKEY OPHTHALMIC DRUGS MARKET SIZE, BY DISEASE CONDITION, 2018-2030 (USD MILLION)
TABLE 266. TURKEY OPHTHALMIC DRUGS MARKET SIZE, BY RETINAL DISORDER, 2018-2030 (USD MILLION)
TABLE 267. TURKEY OPHTHALMIC DRUGS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 268. TURKEY OPHTHALMIC DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 269. TURKEY OPHTHALMIC DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 270. UNITED ARAB EMIRATES OPHTHALMIC DRUGS MARKET SIZE, BY DISPENSE TYPE, 2018-2030 (USD MILLION)
TABLE 271. UNITED ARAB EMIRATES OPHTHALMIC DRUGS MARKET SIZE, BY DISEASE CONDITION, 2018-2030 (USD MILLION)
TABLE 272. UNITED ARAB EMIRATES OPHTHALMIC DRUGS MARKET SIZE, BY RETINAL DISORDER, 2018-2030 (USD MILLION)
TABLE 273. UNITED ARAB EMIRATES OPHTHALMIC DRUGS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 274. UNITED ARAB EMIRATES OPHTHALMIC DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 275. UNITED ARAB EMIRATES OPHTHALMIC DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 276. UNITED KINGDOM OPHTHALMIC DRUGS MARKET SIZE, BY DISPENSE TYPE, 2018-2030 (USD MILLION)
TABLE 277. UNITED KINGDOM OPHTHALMIC DRUGS MARKET SIZE, BY DISEASE CONDITION, 2018-2030 (USD MILLION)
TABLE 278. UNITED KINGDOM OPHTHALMIC DRUGS MARKET SIZE, BY RETINAL DISORDER, 2018-2030 (USD MILLION)
TABLE 279. UNITED KINGDOM OPHTHALMIC DRUGS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 280. UNITED KINGDOM OPHTHALMIC DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 281. UNITED KINGDOM OPHTHALMIC DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 282. OPHTHALMIC DRUGS MARKET, FPNV POSITIONING MATRIX, 2023
TABLE 283. OPHTHALMIC DRUGS MARKET SHARE, BY KEY PLAYER, 2023
TABLE 284. OPHTHALMIC DRUGS MARKET LICENSE & PRICING

Companies Mentioned

  • Abbott Laboratories
  • Alcon Vision LLC
  • Allergan PLC by AbbVie Inc.
  • Apotex Inc.
  • Bausch Health Companies Inc.
  • Bayer AG
  • Carl Zeiss AG
  • Coherus Biosciences, Inc.
  • EyePoint Pharmaceuticals, Inc.
  • Eyevensys
  • Genentech, Inc.
  • Johnson & Johnson Service, Inc.
  • Kodiak Sciences Inc.
  • Lupin Limited
  • Merck & Co.
  • Nicox SA
  • Novaliq GmbH
  • Novartis AG
  • Ocular Therapeutix, Inc.
  • OCuSOFT Inc.
  • Pfizer Inc.
  • Recipharm AB
  • Regeneron Pharmaceuticals, Inc.
  • Santen Pharmaceutical Co., Ltd.
  • Senju Pharmaceutical Co., Ltd.
  • Somerset Pharma, LLC.
  • Sun Pharmaceutical Industries, Inc.
  • Takeda Pharmaceutical Company Limited
  • Teva Pharmaceutical Industries Ltd.
  • Viatris Inc.

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages188
PublishedMarch 2024
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 30.56 Billion
Forecasted Market Value ( USD ) by 2030 $ 43.21 Billion
Compound Annual Growth Rate5.8%
Regions CoveredGlobal
No. of Companies Mentioned30

Related Topics

Related Reports

Global Ophthalmic Drugs Market Size, Share & Trends Analysis Report by Drug Class (Steroidal drugs, Anti-VEGF Agents), Disease, Dosage Form, Route of Administration, Product Type, Product, Region, and Segment Forecasts, 2024-2030 - Product Image

Global Ophthalmic Drugs Market Size, Share & Trends Analysis Report by Drug Class (Steroidal drugs, Anti-VEGF Agents), Disease, Dosage Form, Route of Administration, Product Type, Product, Region, and Segment Forecasts, 2024-2030

  • Report
  • 125 Pages
  • Global
From
Ophthalmic Drugs Global Market Report 2024 - Product Image

Ophthalmic Drugs Global Market Report 2024

  • Report
  • 200 Pages
  • Global
From
Global Ophthalmic Eye Dropper Market Size, Share & Trends Analysis Report by Type (Unidose, Preserved, Preservative-free), Drug Type (Prescription drugs, OTC drugs), Treatment Type (Glaucoma, Allergies), Region, and Segment Forecasts, 2024-2030 - Product Image

Global Ophthalmic Eye Dropper Market Size, Share & Trends Analysis Report by Type (Unidose, Preserved, Preservative-free), Drug Type (Prescription drugs, OTC drugs), Treatment Type (Glaucoma, Allergies), Region, and Segment Forecasts, 2024-2030

  • Report
  • 150 Pages
  • Global
From
Global Ophthalmic Drug Delivery System Market by Technology (Contact Lenses, Episcleral Implants, Eye Drops), Production Technology (3D Printing, Compression Molding, Electrospinning), Material, Delivery Route - Forecast 2024-2030 - Product Image

Global Ophthalmic Drug Delivery System Market by Technology (Contact Lenses, Episcleral Implants, Eye Drops), Production Technology (3D Printing, Compression Molding, Electrospinning), Material, Delivery Route - Forecast 2024-2030

  • Report
  • 197 Pages
  • Global
From
Ophthalmic Drugs Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028 - Product Image

Ophthalmic Drugs Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028

  • Report
  • 138 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.